Crixivan (indinavir) is a small molecule pharmaceutical. Indinavir was first approved as Crixivan on 1996-03-13. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Crixivan's patent is valid until 2021-02-10 (FDA).
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Antivirals: HIV protease inhibitors (saquinavir type)|